Literature DB >> 22044409

Future of the pharmacogenomics of calcineurin inhibitors in renal transplant patients.

Huaijun Zhu, Weihong Ge.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22044409     DOI: 10.2217/pgs.11.129

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


× No keyword cloud information.
  2 in total

1.  Association of CYP3A polymorphisms with the pharmacokinetics of cyclosporine A in early post-renal transplant recipients in China.

Authors:  Xiang-guang Meng; Cheng-xian Guo; Guo-qing Feng; Ying-chun Zhao; Bo-Ting Zhou; Jian-le Han; Xin Chen; Yong Shi; Hong-yao Shi; Ji-ye Yin; Xiang-dong Peng; Qi Pei; Wei Zhang; Guo Wang; Meng He; Min Liu; Jing-ke Yang; Hong-hao Zhou
Journal:  Acta Pharmacol Sin       Date:  2012-10-22       Impact factor: 6.150

Review 2.  CYP3A5 polymorphisms in renal transplant recipients: influence on tacrolimus treatment.

Authors:  Lucy Chen; G V Ramesh Prasad
Journal:  Pharmgenomics Pers Med       Date:  2018-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.